PBE Among Technology ETFs
End-of-day Nov 20, 2026 · 54 Technology ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.7% | −5.4% | −6.8% | −4.8% | +13.9% | +20.8% | +69.2% | +30.8% | +122.0% | +418.1% |
| Peer average | −5.6% | −11.2% | −14.8% | −18.1% | −5.7% | −2.0% | +47.3% | +12.2% | +330.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$59 of every $1,000 in PBE is Biogen
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | BIIBBiogen | Healthcare | 5.85% | $585.20 | 99K | $25.0M |
| 2 | GILDGilead Sciences | Healthcare | 5.84% | $583.65 | 147K | $24.9M |
| 3 | REGNRegeneron Pharmaceuticals | Healthcare | 5.83% | $582.81 | 26K | $24.8M |
| 4 | RPRXRoyalty Pharma | Healthcare | 5.68% | $568.48 | 353K | $24.2M |
| 5 | AMGNAmgen | Healthcare | 5.16% | $515.80 | 50K | $22.0M |
| 6 | VRTXVertex Pharmaceuticals | Healthcare | 4.99% | $498.57 | 40K | $21.3M |
| 7 | ILMNIllumina | Healthcare | 4.80% | $479.62 | 97K | $20.4M |
| 8 | NTRANatera | Healthcare | 4.42% | $441.82 | 65K | $18.8M |
| 9 | VCELVericel | Healthcare | 3.80% | $380.34 | 276K | $16.2M |
| 10 | MRNAModerna | Healthcare | 3.47% | $347.26 | 75K | $14.8M |
| 11 | EXELExelixis | Healthcare | 3.37% | $337.46 | 211K | $14.4M |
| 12 | TGTXTG Therapeutics | Healthcare | 3.34% | $334.39 | 216K | $14.3M |
| 13 | QGENQiagen | Healthcare | 3.18% | $318.23 | 274K | $13.6M |
| 14 | UTHRUnited Therapeutics | Healthcare | 3.12% | $312.09 | 23K | $13.3M |
| 15 | NBIXNeurocrine Biosciences | Healthcare | 2.98% | $297.61 | 78K | $12.7M |
of the $345B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | BIIB | Biogen | 5.85% |
| 2 | GILD | Gilead Sciences | 5.84% |
| 3 | REGN | Regeneron Pharmaceuticals | 5.83% |
| 4 | RPRX | Royalty Pharma | 5.68% |
| 5 | AMGN | Amgen | 5.16% |
| 6 | VRTX | Vertex Pharmaceuticals | 4.99% |
| 7 | ILMN | Illumina | 4.80% |
| 8 | NTRA | Natera | 4.42% |
| 9 | VCEL | Vericel | 3.80% |
| 10 | MRNA | Moderna | 3.47% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.0187 |
| Jun 22, 2026 | Jun 26, 2026 | $0.81 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0824 |
| Dec 22, 2025 | Dec 26, 2025 | $0.42 |
| Sep 22, 2025 | Sep 26, 2025 | $0.23 |
| Jun 23, 2025 | Jun 27, 2025 | $0.13 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0341 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0082 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0242 |
| Jun 20, 2023 | Jun 23, 2023 | $0.0141 |
| Mar 23, 2020 | Mar 31, 2020 | $0.0290 |
| Sep 24, 2018 | Sep 28, 2018 | $0.0021 |